CClinicalTrials.gg
CompletedNCT07090980epilepsyUpdated Jul 29, 2025

Effects of Podcast Education on Medication Perception, Stigma Level, and Epilepsy Self-management in Epilepsy Patients

An interventional study of epilepsy education via podcast in Epilepsy, Stigma and Self Management, sponsored by Istanbul Sabahattin Zaim University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-07-29.

Sponsored by Istanbul Sabahattin Zaim University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2024, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Seventy epilepsy patients who presented to Gaziosmanpaşa Training and Research Hospital as outpatients (diagnosed at least 3 months prior, taking at least one medication, and having access to the internet) were randomly assigned to two groups. 35 patients were assigned to the experimental group, and 35 patients to the control group. All patients were asked to complete a sociodemographic form, self-management form, medication adherence form, and stigma form as pre-tests. The experimental group was exposed to an epilepsy education podcast recorded by the researcher via Spotify. The control group received routine outpatient education provided by the doctor. The same tests were repeated at 1 and 3 months, and the effectiveness of the education was evaluated. Differences between the two groups and changes over time were monitored.

02

Conditions studied

  • Epilepsy
  • Stigma
  • Self Management
  • Drug Therapy

Keywords

  • Epilepsy, podcast, nursing, stigma, self-management, drug perception
03

In context

Epilepsy

1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.

This study's enrollment of 70 is above the median of 50 across 1,205 interventional studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Istanbul Sabahattin Zaim University is the lead sponsor of 25 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Volunteer to participate in the study
  • 18 years of age
  • Diagnosed with epilepsy at least 3 months ago
  • Taking at least one antiepileptic drug

Exclusion criteria

Exclusion Criteria:

  • Being diagnosed with mental retardation
  • Having language and communication barriers
  • Not having sufficient equipment
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    experimental group

    This group was played a podcast containing information about epilepsy

    Other: epilepsy education via podcast

  • No intervention
    control group

    This group received routine outpatient information about epilepsy from their doctor. No additional intervention is required.

Interventions

  • Otherepilepsy education via podcast

    Epilepsy education via podcast has never been provided in any clinical study in Turkey before. By providing education via podcast, we have made health education more accessible and repeatable.

06

What researchers measure

Primary outcomes

  1. first month results

    Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.

    Time frame: 1 month result

Secondary outcomes

  1. third month result

    Members of the intervention and control groups were assessed at the initial meeting using four forms listed by the researchers: the "Patient Information Form," the "Medication Beliefs Questionnaire," the "Feeled Stigma Scale," and the "Self-Management Scale." The control group received routine outpatient clinic education, while the patient group, designated as the intervention group, received education via a six-part podcast containing information about the epilepsy system for approximately 25 people. At the end of the training, both groups were assessed using the same four forms at the end of the first and third months.

    Time frame: three months

07

Study locations

1 site
  • Gaziosmanpaşa Eğitim ve Araştırma Hastanesi
    Istanbul, gaziosmanpaşa 34100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Personal data will not be shared for the purpose of protecting personal data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07090980
Lead sponsor
Istanbul Sabahattin Zaim University
Responsible party
Gökçe Çiçek Yavaş (Principal Investigator, Istanbul Sabahattin Zaim University) — Principal investigator
First posted
Jul 29, 2025
Start date
Nov 25, 2024
Primary completion
May 15, 2025
Completion
May 17, 2025
Last update
Jul 29, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion